Celltrion
068270.KS
#724
Rank
HK$212.26 B
Marketcap
HK$1,036
Share price
0.05%
Change (1 day)
-8.36%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): HK$23.44

According to Celltrion 's latest financial reports the company's current EPS (TTM) is HK$23.23. In 2022 the company made an earnings per share (EPS) of HK$22.62 a decrease over its 2021 EPS that were of HK$26.87.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$23.443.65%
2022HK$22.62-15.84%
2021HK$26.8712.77%
2020HK$23.8370.79%
2019HK$13.9515.63%
2018HK$12.07-33.13%
2017HK$18.05141.17%
2016HK$7.488.28%
2015HK$6.9111.28%
2014HK$6.2116.37%
2013HK$5.34-67.42%
2012HK$16.3884.22%
2011HK$8.8962.13%
2010HK$5.4880.61%
2009HK$3.04-559.63%
2008-HK$0.66-123.16%
2007HK$2.85